Based on this Bloomberg article below.... I'm gonna say YES... The FDA is aware!!! And this is ONLY in FOUR MONTHS (May-Oct)!!! And it's only the ones that were REPORTED!!!
I'm happy to say I'M A MERCK REP!!! And I know the Vertex reps are NOT reporting the rashes to the FDA when offices tell them about it.... But guess what??? I AM!!!!! There have been 2 cases of SJS in my territory due to Incivek and the rep DID NOT report them..... Well no worries!!! Cause I did!! YOU'RE WELCOME VERTEX!!!
VERTEX FALLS AS FDA DATABASE SHOWS INCIVEK ADVERSE EVENTS: Favus
By Sasha Damouni and Clyde Eltzroth
Oct. 26 (Bloomberg) – Vertex down as much as 6.4% after Incivek showed 417 related adverse events (May 23-Oct. 17), entered into FDA Adverse Events Reporting System (AERS), Favus analyst Elliot Favus said in a note after contacting the FDA.
• Toxicity profile of Incivek worse than Favus expected; total of 20 cases of Stevens-
Johnson syndrome (3) and drug rash with eosinophilia and systemic systems (17) have
been reported since Incivek rollout: Favus
• Regulators, investors will begin following ration of SJS/DRESS cases, since the ratio may
become "intolerable" to doctors, patients, FDA: Favus
• SJS, DRESS normally extremely rare, life-threatening, drug-induced skin reactions with
multi-organ system failure: Favus
• VRTX up 11% in last 12 months vs S&P 300 Health Care Index up 9.3%
• VRTX 13 buys, 8 holds, 3 sells, avg. PT $57: Bloomberg data
I'm happy to say I'M A MERCK REP!!! And I know the Vertex reps are NOT reporting the rashes to the FDA when offices tell them about it.... But guess what??? I AM!!!!! There have been 2 cases of SJS in my territory due to Incivek and the rep DID NOT report them..... Well no worries!!! Cause I did!! YOU'RE WELCOME VERTEX!!!
VERTEX FALLS AS FDA DATABASE SHOWS INCIVEK ADVERSE EVENTS: Favus
By Sasha Damouni and Clyde Eltzroth
Oct. 26 (Bloomberg) – Vertex down as much as 6.4% after Incivek showed 417 related adverse events (May 23-Oct. 17), entered into FDA Adverse Events Reporting System (AERS), Favus analyst Elliot Favus said in a note after contacting the FDA.
• Toxicity profile of Incivek worse than Favus expected; total of 20 cases of Stevens-
Johnson syndrome (3) and drug rash with eosinophilia and systemic systems (17) have
been reported since Incivek rollout: Favus
• Regulators, investors will begin following ration of SJS/DRESS cases, since the ratio may
become "intolerable" to doctors, patients, FDA: Favus
• SJS, DRESS normally extremely rare, life-threatening, drug-induced skin reactions with
multi-organ system failure: Favus
• VRTX up 11% in last 12 months vs S&P 300 Health Care Index up 9.3%
• VRTX 13 buys, 8 holds, 3 sells, avg. PT $57: Bloomberg data